CV vs PAYX · rev $3.5M vs P/E 22, rev $5.57B
CapsoVision, Inc. Common Stock (CV) versus Paychex Inc (PAYX) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported PAYX revenue for 2025-05-31 was $5.57B. Net income was $1.66B. Revenue was up 5.6% from 2024-05-31 to 2025-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
CV currently screens at market cap $359.2M. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Not investment advice. Open the CV and PAYX stock pages for the full models.
Not investment advice.